Qualified Settlement Fund

Background

Qualified Settlement Fund (QSF) is a court-established account used to hold and distribute settlement dollars in mass tort cases, such as the nationwide opioid litigation. In West Virginia, opioid settlement funds are deposited into a QSF and distributed according to the terms of the West Virginia First Memorandum of Understanding (MOU)a landmark agreement designed to ensure that these funds are used transparently, equitably, and for maximum public health impact.

In May 2023, the West Virginia First Foundation (WVFF) was formally established to manage the majority share of opioid settlement funds outlined in the MOU. As a private nonprofit, WVFF oversees the long-term, evidence-based distribution of these funds across six regions to support prevention, treatment, and recovery efforts statewide. The remaining shares are outlined as follows:

  • 72.5% of the funds are managed by WVFF, a private nonprofit charged with overseeing the long-term, evidence-based distribution of opioid settlement dollars across six regions. The Foundation supports prevention, treatment, and recovery initiatives through strategic grantmaking and statewide planning.

  • 24.5% of the funds are distributed directly to Local Governments, providing them with flexible resources to meet urgent community needs. These funds are separate from those administered by the Foundation, though WVFF is responsible for collecting and reporting on local expenditures annually.

  • 3% of the funds are allocated to the Office of the West Virginia Attorney General, supporting statewide enforcement, compliance, and coordination efforts. These funds are also separate from the Foundation’s oversight.

The funds allocated from the Qualified Settlement Fund (QSF) to the Local Governments and Attorney General do not pass through WVFF; they flow directly from the QSF to the Local Governments and Attorney General. WVFF does not oversee how Local Governments use their 24.5% share; however, WVFF is responsible for collecting data and reporting those expenditures in accordance with the MOU.

Resources for Navigating Opioid Settlement Funds

While the West Virginia First Foundation (WVFF) does not oversee the 24.5% of opioid settlement funds distributed directly to counties and municipalities, nor the 3% allocated to the Office of the West Virginia Attorney General, the Foundation is committed to transparency and public understanding of the broader opioid settlement landscape.

In collaboration with the Office of the West Virginia Attorney General, WVFF is developing educational materials and resources to help Local Governments better understand how to responsibly and transparently use their settlement funds. Updates and guidance will be made available at wvfirst.org.

Questions?

If you have questions, please visit our  Contact Us  page. Submitting inquiries through this form helps us track and respond efficiently while also building a database of frequently asked questions to better serve all West Virginians.

2025 Annual QSF Expenditure Report for Local Governments

While WVFF does not oversee how local governments use their 24.5% share, it is responsible for collecting and reporting those expenditures in accordance with the Memorandum of Understanding.

If any inaccurate information or data within this report is noticed, please contact finance@wvfirst.org so we can address and update it accordingly.

MOU Approved Purposes

  • Treat Opioid Use Disorder (OUD)
  • Support People in Treatment and Recovery
  • Connect People Who Need Help to the Help They Need (Connections to Care)
  • Address the Needs of Criminal-Justice-Involved Persons
  • Address the Needs of Pregnant or Parenting Women and Their Families, Including Babies with Neonatal Abstinence Syndrome
  • Prevent Over-Prescribing and Ensure Appropriate Prescribing and Dispensing of Opioids
  • Prevent Misuse of Opioids
  • Prevent Overdose Deaths and Other Opioid-Related Injuries
  • First Responders
  • Leadership, Planning and Coordination
  • Training
  • Research
  • Law Enforcement

MOU Core Strategies

  • Naloxone or other FDA-Approved Drug to Reverse Opioid Overdoses
  • MAT Distribution and other Opioid Related Treatment
  • Pregnant and Postpartum Women
  • Expanding Treatment for Neonatal Abstinence Syndrome
  • Expansion of Warm Hand-Off Programs and Recovery Services
  • Treatment for Incarcerated Population
  • Prevention Programs
  • Evidence-Based Data Collection and Research Analyzing the Effectiveness of the Abatement Strategies within the State
  • Law Enforcement
  • Research
Scroll